Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Med Decis Making. 2014 Oct 20;35(1):60–67. doi: 10.1177/0272989X14553472

Germs are Germs, and Why Not Take a Risk?: Patients’ Expectations for Prescribing Antibiotics in an Inner City Emergency Department

David A Broniatowski 1,*, Eili Y Klein 2, Valerie F Reyna 3
PMCID: PMC4270903  NIHMSID: NIHMS627491  PMID: 25331913

Abstract

Background

Extensive use of unnecessary antibiotics has driven the emergence of resistant bacterial strains, posing a threat to public health. Physicians are more likely to prescribe antibiotics when they believe that patients expect them. Current attempts to change these expectations highlight the distinction between viruses and bacteria (“Germs are Germs”). Fuzzy Trace Theory further predicts that patients expect antibiotics because they make decisions based on categorical gist, producing strategies that encourage risk taking when the status quo is bad (i.e., “Why Not Take a Risk?”). We investigate both hypotheses.

Methods

We surveyed patients visiting the emergency department of a large urban hospital (72, 64%, were African-American) using 17 Likert-scale questions and two free-response questions regarding patient expectations for antibiotics.

Results

After the clinical encounter, 113 patients completed the survey. 54 (48%) patients agreed with items that assess the “Germs are Germs” hypothesis, whereas 86 (76%) agreed with items that assess the “Why Not Take a Risk?” hypothesis. “Why Not Take a Risk?” captures significant unique variance in a factor analysis, and is neither explained by “Germs are Germs,” nor by patients’ lack of knowledge regarding side effects. Of the 81 patients who rejected the “Germs are Germs” hypothesis, 61 (75%) still indicated agreement with the “Why Not Take a Risk?” hypothesis. Several other misconceptions were also investigated.

Conclusions

Our findings suggest that recent public health campaigns that have focused on educating patients about the differences between viruses and bacteria omit a key motivation for why patients expect antibiotics, supporting Fuzzy Trace Theory’s predictions about categorical gist. The implications for public health and emergency medicine are discussed.


Antibiotic resistance has become a major threat to the public and patient health. Despite the magnitude of the problem, antibiotics are over-prescribed, due in large part to patients’ expectations for antibiotic therapy. Studies show that physicians often prescribe antibiotics based on their beliefs about what patients expect (1-3), even though available data suggest that physicians have difficulty divining patients’ expectations (3). When expectations are clear, physicians can address those expectations directly with patients, resulting in more accurate diagnoses and more satisfied patients (4). However, there is a lack of understanding of how patients’ expectations regarding antibiotics are formed. For example, Butler et al. (3) hypothesized that patients may conflate antibiotics with treatment in general. In addition, Stearns et al. (5) hypothesized several reasons for why patients might expect antibiotics, including that receiving antibiotics provides them with a retroactive justification for taking the time and effort to visit the hospital, and because it is a signal that the physician takes their illness seriously. Such patients might expect antibiotics as a natural outcome of visiting a physician, even if their illness is not bacterial or does not require such therapy.

The issue of how patients understand the meaning of antibiotics is central to any patient-centered educational intervention that attempts to address inappropriate antibiotic prescribing. Thus, we examined patients’ expectations regarding antibiotic therapy using Fuzzy Trace Theory (FTT), a theory of medical decision-making that helps explain how people form judgments and make decisions based on the meanings that they derive from the information they are given (e.g., 6). FTT therefore highlights the importance of understanding the meaning of “antibiotics” to patients.

FTT posits that individuals encode at least two mental representations of information, called verbatim traces and gist traces. Verbatim traces are precise representations of the surface form of information (“If I take antibiotics, there is a 0.1% chance of negative side effects”), whereas gist traces are qualitative representations of the meaning of information (“If I take antibiotics, mostly nothing bad will happen,” i.e., its bottom-line meaning). Although people process both types of information, evidence suggests that they generally rely on gist, rather than verbatim, representations (6-10).

Hypotheses

Germs are Germs

Perhaps the most prominent hypothesis regarding why patients expect antibiotics is that they do not know the difference between bacteria and viruses, and will therefore assume that antibiotic treatment is effective against viral illness. We call this hypothesis “Germs are Germs” because it captures the gist of many peoples’ conceptualizations of disease-causing microorganisms, as shown in prior FTT research on sexually transmitted infections (6, 7). If this hypothesis is correct, then it should be remedied by patient education that explains the differences between viral and bacterial illnesses, such as the U.S. Centers for Disease Control and Prevention’s (CDC) Get Smart program (11), but not by experience with antibiotics alone, because patients are often unable to distinguish the disease courses of bacterial and viral infections.

Why Not Take a Risk?

We propose an alternative hypothesis, based on FTT, that patients draw a categorical contrast between possibly effective treatment and certainly remaining sick (cf. 16). Patients who make such categorical distinctions should seek antibiotic therapy if there is a non-negligible possibility that their symptoms are caused by a bacterial pathogen and could improve with antibiotics. This strategy would be especially likely if antibiotics are perceived to be essentially without risk – i.e., if taking antibiotics is perceived as basically harmless to the individual.

Therefore, we constructed several items to assess this strategic risk hypothesis, drawing on prior research (12-14) that used such items as “Better safe than sorry” (e.g., “Antibiotics might not make me better, but it is better to be safe than sorry so I should take them”), and adding new items, such as “I don’t know if an antibiotic can make me better, but it can’t hurt to take them” and “Antibiotics might not make me better, but I should take them just in case.” We also included items to tease apart this strategic approach to risk from lack of knowledge and a variety of misconceptions identified in prior literature and in our interviews with physicians who are experts on the use of antibiotics (sources are shown in Table 1).

Table 1.

Mean Agreement for Positive (+) or Disagreement for Negative (−) Items Describing the Gist of Antibiotics Expectations by Hypothesis

Item short form Code Item full text N Mean
(SD)
Correct Knowledge (11)
 Yes against bacteria + Antibiotics work against bacteria. 66 3.89 (0.70)
 No against bacteria Antibiotics don’t work against
bacteria.
46 3.59 (0.82)
Germs are Germs (11)
 Yes against viruses + Antibiotics work against viruses. 57 3.07 (1.01)
 No against viruses Antibiotics don’t work against viruses. 56 2.96 (1.07)
 Yes against
 germs
+ Antibiotics work against all germs. 56 2.64 (0.91)
 No against germs Antibiotics only work against some
germs.
57 2.35 (0.85)
Why Not Take a Risk? (4)
 Better safe than sorry + Antibiotics might not make me better,
but it is better to be safe than sorry so I
should take them
61 3.43 (1.03)
 Better not to take ABX Antibiotics might not make me better,
so I shouldn’t take them
52 3.44 (1.05)
 Take ABX just in case + Antibiotics might not make me better,
but I should take them just in case
57 3.17 (0.95)
 Don’t take ABX if they
 don’t make me better
I shouldn’t take antibiotics if they
might not make me better
55 2.85 (1.09)
 It can’t hurt + I don’t know if an antibiotic can make
me better, but it can’t hurt to take them
55 3.15 (1.05)
 It might hurt I don’t know if an antibiotic can make
me better, but there might be side
effects if I take them
58 2.41 (0.77)
Antibiotics Might Have Side Effects (4)
 ABX might have side
 effects
+ Antibiotics might have side effects, so
I should only take them when I know
they will work
69 3.71 (0.96)
 ABX don’t have side
 effects
Antibiotics are not harmful, so I
should take them even if they might
not work
44 3.23 (1.02)
I Need Antibiotics to Get Better (3)
 My symptoms need
 ABX
+ My symptoms will only go away with
antibiotics
52 2.98 (0.99)
 My symptoms don’t
 need ABX
My symptoms will go away without
antibiotics
61 3.18 (1.00)
 Will get better without
 ABX
+ I will get better even if I don’t take
antibiotics
54 2.80 (0.97)
 Won’t get better
 without ABX
I won’t get better unless I take
antibiotics
59 3.24 (1.06)
Antibiotics Will Make Me Better (Expert Physician Interview)
 ABX will make me
 better
+ If I take antibiotics I will get better. 58 3.41 (0.97)
 ABX will keep me sick If I take antibiotics I won’t get better 55 3.56 (0.91)
 ABX always cure + Antibiotics always cure my symptoms 48 2.94 (0.99)
 ABX don’t always cure Antibiotics don’t always cure my
symptoms
65 2.66 (1.00)
Doctors Are Supposed to Give Antibiotics (5)
 Dr. takes me seriously
 so gives ABX
+ If a doctor takes my illness seriously,
they will give me an antibiotic
61 3.48 (0.74)
 Dr. takes me seriously
 regardless of ABX
A doctor who takes my illness
seriously will only give me an
antibiotic if I need it
63 4.02 (0.74)
 Dr. may not give ABX
 even if s/he believes me
+ A doctor will not always give me an
antibiotic, even if they believe that I
am really sick
50 2.98 (1.09)
 Dr. doesn’t believe me If a doctor doesn’t give me an
antibiotic, the doctor doesn’t believe
that I am really sick
63 3.71 (0.88)
 Dr. knows best + A good doctor knows best when
antibiotics are needed
54 4.22 (0.60)
 Dr. doesn’t know best Even a good doctor doesn’t always
know best when antibiotics are needed
59 2.95 (1.05)
 I trust Dr. to give ABX
 when I’m sick
+ I trust the doctor will give me an
antibiotic if I am sick
55 3.64 (0.98)
 I trust Dr. to give ABX
 only when needed
I trust the doctor will only give me an
antibiotic if I need it
58 3.96 (0.64)
I Visit the Doctor for an Antibiotic (5)
 ABX are worth seeing
 Dr.
+ It is worth it to go to the
doctor/emergency room because I will
get an antibiotic
64 2.92 (0.96)
 Seeing Dr. worth it
 without ABX
Going to the doctor/emergency room
is worth it even if I do not get an
antibiotic
49 2.31 (0.93)
 Dr. gives ABX if I feel
 bad
+ I feel bad enough to have come to the
doctor/emergency room so I should get
an antibiotic
63 2.86 (1.12)
 Feeling bad doesn’t
 mean Dr. gives ABX
Just because I feel bad enough to come
to the doctor/emergency room, doesn’t
mean I need an antibiotic
50 2.14 (0.80)

Note. Each survey contained either the forward (+) or reverse-coded (−) version (randomly assigned) of each question. Agreement was scored from 1 (strongly disagree) to 5 (strongly agree). Mean values reported for reverse-coded items above indicate disagreement, for ease of comparison to forward-coded items. A source reference for each gist is given in parentheses.

Methods

Selection and Description of Participants

Patients were administered a paper survey between January and April 2013 in the emergency department (ED) of a large urban hospital. The hospital is a level-one trauma center and the ED serves as a primary source of emergency care for the surrounding, predominately African-American, community. Research staff approached patients presenting to the ED after they were seen by the ED physician (some were still awaiting medical supplies or test results), prior to discharge. Surveys were completed anonymously. Patients 18 years and older were eligible. English literacy was not an explicit criterion; experienced research staff enrolled available patients who were capable of responding to questioning (e.g., were lucid, could understand English etc.). No incentives were offered. The protocol was approved by the Johns Hopkins University (JHU) School of Medicine Institutional Review Board (IRB-X #NA_00081478).

Technical Information

The survey consisted of 17 Likert-scale items (see Table 1), followed by two free-response questions, demographic information including age, race/ethnicity and level of education, and, last, reason for the visit. Each question about antibiotics was based on the published literature or expert physician interviews. The questions were directed at attitudes towards antibiotics in general rather than to the specific visit. Responses were recorded using a 1-5 Likert scale, ranging from Strongly Disagree to Strongly Agree. In order to ensure that question wording did not bias responses, each question was presented in either a forward- or reverse-coded version. For example, patients who strongly agree (5) that antibiotics work against bacteria should strongly disagree (1) with the statement that antibiotics don’t work against bacteria. A computer generated individual surveys that were administered by staff such that the order of questions and the direction in which they were asked were randomized. The free-response questions were “Why should someone take antibiotics?” and “What is the difference between viruses and bacteria?”

Statistics

Because patients were randomly assigned to different versions of questions, total responses for each question varied slightly (see Table 1). Correlations of item agreement with age and education were conducted to determine whether these characteristics were related to antibiotics knowledge, misconceptions, and risk strategies. An exploratory factor analysis (EFA) was also conducted to find clusters of questions that had been answered similarly across participants. These clusters (or dimensions) were inspected to identify gist themes underlying responses. There was no forced extraction of components. The oblimin rotation method was used with maximum likelihood extraction. Three factors were retained based upon standard (15) goodness-of-fit criteria (root mean square error of approximation [RMSEA] = 0.01, 95% upper confidence bound = 0.05; examination of parallel analysis scree plot; Tucker-Lewis Index [TLI] = 1.10). Results were robust across multiple different analysis methodologies (Technical Appendix, Tables 3, 4, & 5). EFA was conducted using version 3.0.2 of the R Project for Statistical Computing.

Role of Funding Source

The funding source had no role in study design or implementation.

Results

Sample Characteristics

Data were collected for 113 patients. The majority of our sample was African-American with at most a high school education (Table 2). Sample characteristics were broadly representative of the JHU annual ED population (Technical Appendix, Table 6). Controlling for multiple tests, there was no significant difference in survey responses between patients whose presenting complaints indicated that they were likely to expect antibiotics (e.g., presenting with flu-like symptoms) and those who were unlikely to expect antibiotics (e.g., presenting with trauma).

Table 2.

Statistics for 113 patients in our sample

Category Characteristic N (%)
Race/Ethnicity African-American 72 (64%)
White non-Hispanic 34 (30%)
Hispanic 3 (3%)
Asian 2 (2%)
Native American 1 (1%)
No response 1 (1%)

Age <24 10 (9%)
25-29 20 (18%)
30-39 17 (15%)
40-49 18 (16%)
50-64 27 (24%)
>65 20 (18%)
No response 1 (1%)

Educational attainment Did not complete high school 23 (20%)
High school or equivalent 50 (44%)
Some college 21 (19%)
Associates’ degree 6 (5%)
Bachelors’ degree 9 (8%)
Masters’ degree 1 (1%)
Doctorate degree 2 (2%)
No response 1 (1%)

Patients’ Presenting Complaints Likely to expect antibiotics 21 (19%)
Unlikely to expect antibiotics 70 (62%)
Indeterminate 21 (19%)
No response 1 (1%)

Patients’ Knowledge and Misconceptions Regarding Antibiotics

Mean responses for each question asked are shown in Table 1. Most patients (84; 75%) displayed some correct knowledge, agreeing that antibiotics work against bacteria (or disagreeing that antibiotics don’t work against bacteria). However, many patients also had misconceptions. For example, 48 (42%) patients agreed that antibiotics work against viruses (or disagreed that antibiotics don’t work against viruses). When asked about the difference between viruses and bacteria in free-response questions, 45 (40%) patients stated that they were unsure or did not know. Furthermore, 33 (29%) patients spontaneously reported misconceptions that were factually inaccurate. Specifically, 11 (10%) responses related to misconceptions concerning the mechanism of transmission (e.g., that viruses were airborne whereas bacteria were found on dirty surfaces), 10 responses (9%) indicated that one sort of infection is external “gets in your body” whereas the other is internal “grows in your body,” 5 responses (4%) indicated that either bacteria or viruses were more dangerous or contagious, one patient said viruses but not bacteria can be cured, and 3 responses (3%) indicated that there was no difference between viruses and bacteria; 11 (10%) patients did not answer.

Why Not Take a Risk?

A majority of patients (86; 76%) agreed with at least one item (or disagreed with a reverse-coded variant) supporting the “Why Not Take a Risk?” gist. In addition, EFA results showed that the “Why Not Take a Risk?” gist captured a significant amount of unique variance (Technical Appendix; Table 3). Both item-pairs loading on this dimension highlight the perception of possible gain, but negligible downside risk associated with taking antibiotics.

Germs are Germs

In contrast to the “Why Not Take a Risk?” gist, less than half of patients (54; 48%) agreed with at least one item supporting the “Germs are Germs” gist. More educated patients were less likely to agree with the items in this gist theme that referred specifically to viruses (Technical Appendix; Table 7). “Germs are Germs” is only weakly correlated with other dimensions in the EFA (r=0.16 with “Why Not Take a Risk?” and r=0.09 with “Antibiotics Might Have Side Effects”). Of the 81 (72%) patients who disagreed with “Germs are Germs,” a majority (61; 75%) still agreed with at least one item supporting “Why Not Take a Risk?”

Side Effects are Related to, but Distinct From, “Why Not Take a Risk?”

Of the 75 patients who agreed that antibiotics might have side effects, a majority (52; 69%) agreed with at least one item indexing the “Why Not Take a Risk?” gist. Nevertheless, these two concepts are distinct because they load on separate dimensions of the EFA and are only weakly correlated (r=0.12). More educated patients were less likely to agree with individual items that emphasize the absence of downside risk such as “It can’t hurt,” and “ABX don’t have side effects” but not with their reverse coded variants that explicitly mention the words “side effects.”

Discussion

Our findings suggest that the conventional approach taken by the CDC’s Get Smart program, which seeks to educate patients about the differences between viruses and bacteria (i.e., “Germs are Germs”), is targeting an important misconception, reflected in both our survey and open-ended responses. This misconception – that bacterial and viral diseases can be lumped together and are both curable with antibiotics – has been used to explain risk judgments for sexually transmitted infections (6,7) and has been the target of successful interventions to reduce risk (14). However, fewer than half of patients in this study agreed with the misconception that antibiotics work against viruses. As predicted by Fuzzy Trace Theory, our data indicate that many patients endorse a distinct strategy, grounded in treating risk categorically, that promotes antibiotic use. That is, most patients agreed with items expressing the “Why Not Take a Risk?” gist – i.e., that antibiotic use boils down essentially to a choice between (a) Don’t take antibiotics and stay sick for sure versus (b) Take antibiotics and maybe stay sick but maybe get better. This gist representation is consistent with Fuzzy Trace Theory, which predicts that option b will be chosen because getting better is superior to staying sick. A majority of patients who rejected “Germs are Germs” still endorsed a gist strategy of “Why Not Take a Risk?”

One might think that educating patients about the side effects and adverse events associated with antibiotic therapy would be sufficient to change their behaviors, since “Why Not Take a Risk?” is premised on a perception of nil additional downside risk. Indeed, our results suggest that, as patients’ perceptions of downside risk increase, they are less likely to behave strategically. We may therefore conclude that “Why Not Take a Risk?” contains two subtly different interpretations, one focusing on the absence of downside risk (i.e., “Antibiotics don’t have side effects” and “It can’t hurt;”), and the other focusing on the presence of potential upside gain (i.e., “Better safe than sorry,” and “Take ABX just in case”).

Implications for Educational Interventions

This study suggests that educational interventions that focus on microbial distinctions may be insufficient to reduce patients’ expectations for antibiotics. For example, conveying that viruses are smaller than bacteria or that viruses cannot survive outside of the body (11), are unlikely to be perceived as relevant to patients’ decisions about antibiotic use. Indeed, studies have found that explanations regarding antibiotics’ lack of effectiveness against viral infections were not well understood (4), and there is some reason to believe that this would be especially true for the least educated patients – in our sample, most patients had, at most, a high school education. When interpreted in light of other FTT research on risk-taking (16), this study’s results suggest that conventional strategies aimed at educating patients regarding potential side effects and other downside risks must communicate that such risks are both qualitatively worse than the status quo of being sick (e.g., 17-24), and that there is virtually no upside potential to inappropriate antibiotic use. Communications that explicitly focus on communicating that antibiotics are harmful – rather than providing verbatim data – may shift patient preferences (4, 25). Most effective would be an approach that communicates that antibiotics will not help – i.e., will not improve upon the status quo – while simultaneously emphasizing that they can have side effects that are more serious than the symptoms currently encountered by the patient. This will simultaneously address the perception of upside gain and the absence of downside risk that is implied by the “Why Not Take a Risk?” gist.

These results suggest that FTT might profitably apply to other clinical questions. For example, decisions to seek cancer-screening, escalate care (e.g., take riskier medications), or adhere to preventive medication may also be governed by patients’ perceptions of simple qualitative contrasts between the “status quo” of being “okay” (i.e., without apparent disease) versus the categorical possibilities of being either okay or not okay by taking action (e.g., 4, 6, 9). Because being okay is preferred over not being okay, the risky option of taking action would not be a preferred decision for such patients. In contrast, when the status quo changes such that the patient is now “sick” or has a finding, treatment will be preferred, even if it may not be warranted. Targeted educational interventions that directly address these gists are more likely to succeed than those that only address verbatim facts (e.g., 26, 27). Appropriate gist representations are also predicted to more reliably cue relevant social and moral values.

Limitations and Directions for Future Work

Although our study is representative of an urban, low socio-economic status ED patient population, it is not nationally representative and so might not generalize to other populations. In addition, the sickest patients, and those experiencing the most pain, were less likely to be responsive and therefore more likely to be excluded from our sample for practical reasons. In addition, we did not limit our analysis to those patients who are the most likely to expect antibiotics – i.e., those experiencing cold- and flu-like symptoms – rather, we surveyed all patients regardless of their reported ailment. Most expressed some level of support for antibiotic use in general, regardless of their current complaints. Finally, we did not measure changes in patient behavior. Responses to our survey were beliefs and attitudes, which are known to predict behavior, but future studies should link these responses to patient requests for antibiotics in the context of clinical care.

Conclusions

Patient educational interventions may be more effective if they explicitly address the strategic gist (i.e., Why Not Take a Risk?) that patients employ in understanding and choosing antibiotics.

Acknowledgments

Financial support for this study was provided in part by a grant from the National Institutes of Health (DP1OD003874) and by The National Center for the Study of Preparedness and Catastrophic Event Response (PACER) at the Johns Hopkins University, through the U.S. Department of Homeland Security Grant N00014-06-1-0991. The funding agreement ensured the authors’ independence in designing the study, interpreting the data, writing, and publishing the report.

Technical Appendix

Table 3.

Item Loadings Based on an Exploratory Factor Analysis with Oblimin Rotation For 17 Survey Items

1 (8%) 2 (8%) 3 (7%)
Correct Knowledge
Yes against bacteria / No against bacteria −0.41
Germs are Germs
Yes against viruses / No against viruses 0.60
Yes against germs / No against germs
Why Not Take a Risk?
Better safe than sorry / Better not to take ABX 0.43
Take ABX just in case / Don’t take ABX if they don’t make me
better
0.53
It can’t hurt / It might hurt
Antibiotics Might Have Side Effects
ABX have side effects / ABX don’t have side effects 0.99
I Need Antibiotics to Get Better
My symptoms need ABX/ My symptoms don’t need ABX
Will get better without ABX / Won’t get better without ABX
Antibiotics Will Make Me Better
ABX will make me better / ABX will keep me sick
ABX always cure / ABX don’t always cure
Doctors Are Supposed to Give Antibiotics
Dr. takes me seriously so gives ABX / Dr. takes me seriously
regardless of ABX
Dr. may not give ABX even if s/he believes me / Dr. doesn’t
believe me
Dr. knows best / Doctor doesn’t know
I Visit the Doctor for an Antibiotic
I trust Dr. to give ABX when I’m sick / I trust Dr. to give ABX
only when needed
ABX are worth seeing Dr. / Seeing Dr. worth it without ABX
Dr. gives ABX if I feel bad / Feeling bad doesn’t mean Dr.
gives ABX
0.54

Note. Factor loadings >0.40 are shown.

Table 4.

Item Loadings Based on a Principal Component Analysis with Varimax Rotation For 17 Survey Items.

1 (10%) 2 (10%) 3 (9%) 4 (9%) 5 (9%) 6 (8%) 7 (8%)
Correct Knowledge
 Yes against
 bacteria / No
 against bacteria
0.77
Germs are Germs
 Yes against viruses
 / No against
 viruses
0.61
 Yes against germs
 / No against germs
0.76
Why Not Take a Risk?
 Better safe than
 sorry / Better not
 to take ABX
0.77
 Take ABX just in
 case / Don’t take
 ABX if they don’t
make me better
0.66
 It can’t hurt / It
 might hurt
0.47
Antibiotics Might Have Side Effects
 ABX have side
 effects / ABX
 don’t have side
 effects
0.80
I Need Antibiotics to Get Better
 My symptoms
 need ABX/ My
 symptoms don’t
 need ABX
0.48
 Will get better
 without ABX /
 Won’t get better
 without ABX
−0.85
Antibiotics Will Make Me Better
 ABX will make
 me better / ABX
 will keep me sick
0.69
 ABX always cure /
 ABX don’t always
 cure
0.79
Doctors Are Supposed to Give Antibiotics
 Dr. takes me
 seriously so gives
 ABX / Dr. takes
 me seriously
 regardless of ABX
0.73
 Dr. may not give
 ABX even if s/he
 believes me / Dr.
 doesn’t believe me
0.49
 Dr. knows best /
 Doctor doesn’t
 know
0.67
 I trust Dr. to give
 ABX when I’m
 sick / I trust Dr. to
 give ABX only
 when needed
I Visit the Doctor for an Antibiotic
 ABX are worth
 seeing Dr. / Seeing
 Dr. worth it
 without ABX
0.67
 Dr. gives ABX if I
 feel bad / Feeling
 bad doesn’t mean
 Dr. gives ABX
0.43 0.44

Note. Factor loadings >0.40 are shown. Each component with an eigenvalue larger than one was retained. Additional components extracted in the PCA, but not retained in the EFA, suggested other gists held by patients. The fifth factor could be characterized as “I won’t get better unless I take antibiotics”. The sixth factor could be characterized as “Antibiotics will make me better”. The seventh factor may be understood as “Doctors are supposed to give antibiotics”.

Table 5.

Survey Item Bivariate Correlations

Items 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34
1 Yes against bacteria
2 No against bacteria N/A
3 Yes against viruses −0.39* 0.27
4 No against viruses 0.13 −0.23 N/A
5 Yes against germs 0.15 0.15 0.49* −0.16
6 No against germs 0.07 −0.01 −0.13 0.20 N/A
7 Better safe than sorry −0.09 0.03 0.41* −0.21 0.11 −0.11
8 Better not to take ABX 0.22 0.14 0.29 −0.12 0.20 0.19 N/A
9 Take ABX just in case −0.25 −0.09 0.40* 0.19 0.27 0.04 0.44** −0.15
10 Don’t take ABX if they don’t make me better −0.42* 0.22 0.34 0.18 0.05 0.22 −0.46* 0.26 N/A
11 It can’t hurt −0.42* 0.09 0.42* −0.23 0.27 0.13 0.69*** 0.32 0.55** 0.06
12 It might hurt −0.44** 0.17 0.13 −0.12 −0.10 −0.04 −0.33 0.37 0.03 0.27 N/A
13 ABX might have side effects −0.22 0.10 0.41* 0.08 0.16 0.07 −0.24 0.11 −0.35* 0.27 −0.34 0.33*
14 ABX don’t have side effects 0.18 −0.30 0.46* −0.28 0.60** 0.36 0.32 0.77*** 0.61** 0.06 0.45* 0.24 N/A
15 My symptoms need ABX −0.28 0.09 0.50* 0.01 0.51** −0.26 0.33 −0.16 0.35 −0.26 0.39 −0.22 0.15 0.12
16 My symptoms don’t need ABX 0.30 0.08 0.00 0.22 0.37* 0.43* −0.25 0.07 0.33 0.17 0.08 −0.44* −0.11 0.56** N/A
17 Will get better without ABX −0.08 0.13 −0.04 −0.12 0.51** 0.28 −0.29 −0.28 −0.07 0.20 −0.06 0.36 0.17 −0.11 −0.37 0.47**
18 Won’t get better without ABX −0.25 0.09 0.21 0.04 0.24 0.10 0.27 0.24 0.49** 0.02 0.49** 0.08 −0.06 0.28 0.51** 0.07 N/A
19 ABX will make me better 0.33 0.42* 0.23 0.10 0.29 −0.09 −0.01 0.50** 0.22 −0.01 −0.29 −0.33 −0.15 0.20 0.40* −0.07 −0.09 0.52**
20 ABX will keep me sick 0.08 0.63** 0.13 0.24 0.25 −0.24 −0.08 −0.02 −0.18 0.47* 0.11 0.03 0.16 0.19 −0.07 0.07 0.29 0.22 N/A
21 ABX always cure 0.22 0.11 0.11 0.01 0.71*** 0.22 0.24 0.14 0.13 0.10 −0.12 −0.58** 0.05 0.25 0.25 0.58** −0.15 −0.24 0.48** −0.18
22 ABX don’t always cure 0.22 0.40 −0.20 −0.09 0.01 −0.15 −0.23 −0.11 −0.08 0.14 −0.06 0.27 0.25 −0.12 0.13 0.28 0.16 −0.19 −0.32 0.03 N/A
23 Dr. takes me seriously so gives ABX −0.13 0.01 0.46* 0.28 0.44* 0.29 0.19 0.36 0.66*** 0.22 0.39 0.04 −0.26 0.47* 0.40 0.43* 0.12 0.55** 0.34 −0.01 0.15 −0.38*
24 Dr. takes me seriously regardless of ABX 0.29 0.13 −0.15 −0.15 0.14 −0.13 0.08 0.40* −0.11 −0.51** −0.02 −0.11 −0.03 0.22 0.00 −0.28 −0.52** 0.19 0.63*** −0.05 0.00 −0.01 N/A
25 Dr. may not give ABX even if s/he believes me 0.27 0.27 −0.23 0.00 −0.09 −0.04 −0.09 0.33 0.01 0.70*** 0.19 0.34 0.05 0.17 −0.49* 0.06 −0.31 0.05 −0.09 0.17 −0.12 0.24 −0.27 −0.01
26 Dr. doesn’t believe me −0.21 0.21 0.33 −0.04 0.14 −0.24 0.28 0.30 0.36* −0.05 0.46* 0.24 −0.17 0.32 −0.14 −0.15 0.01 0.41* 0.09 0.37* 0.00 −0.19 0.05 0.06 N/A
27 Dr. knows best 0.22 −0.22 −0.01 0.18 0.30 0.10 0.30 −0.11 0.28 0.18 −0.09 −0.21 0.09 0.10 −0.04 0.14 0.02 −0.31 −0.09 −0.38 0.31 0.01 0.37 0.01 0.32 −0.24
28 Dr. doesn’t know best −0.05 0.22 0.07 −0.26 0.18 −0.03 −0.04 0.04 0.09 0.21 0.35 0.09 −0.29 0.20 0.07 0.28 0.28 0.08 −0.03 0.07 0.29 0.35* 0.24 −0.03 0.13 0.05 N/A
29 I trust Dr. to give ABX when I’m sick 0.00 −0.23 0.26 0.06 0.47* 0.43* 0.38 0.30 0.08 −0.03 0.40* −0.15 0.00 0.31 0.34 0.03 0.09 −0.24 0.10 0.12 0.53* 0.22 0.28 −0.14 −0.31 −0.01 0.21 −0.09
30 I trust Dr. to give ABX only when needed 0.31 −0.04 0.23 0.05 0.34 −0.04 0.21 0.13 0.21 −0.34 −0.01 −0.23 −0.07 0.21 −0.02 0.24 0.10 −0.14 0.35 −0.03 0.49** −0.17 0.41* 0.69*** −0.55* 0.07 0.33 −0.42* N/A
31 ABX are worth seeing Dr. 0.08 0.20 0.59** −0.22 0.51** −0.09 0.14 0.34 0.16 −0.11 0.70*** 0.19 −0.08 0.44* 0.50** −0.02 −0.11 0.32 0.28 −0.02 0.05 0.01 0.41* 0.13 0.19 0.17 −0.12 0.15 0.23 −0.04
32 Seeing Dr. worth it without ABX −0.11 −0.19 0.11 0.39 0.02 0.19 0.06 0.16 0.24 −0.01 0.20 −0.12 0.00 0.33 −0.01 0.36 −0.09 −0.03 0.00 −0.49* −0.15 −0.11 0.37 0.26 −0.11 −0.08 −0.02 0.07 0.16 −0.13 N/A
33 Dr. gives ABX if I feel bad −0.06 0.06 0.63*** −0.22 0.36* 0.13 0.14 0.14 0.53** 0.05 0.49** −0.02 −0.38* 0.39* 0.12 0.18 −0.26 0.21 −0.11 −0.29 0.23 −0.11 0.34 −0.01 −0.11 0.12 −0.11 −0.03 0.20 0.25 0.49** 0.30
34 Feeling bad doesn’t mean Dr. gives ABX 0.38* −0.28 −0.34 0.23 −0.13 0.16 −0.13 −0.17 −0.15 −0.10 −0.26 −0.01 0.12 0.11 −0.47* 0.31 −0.17 −0.58** −0.31 −0.41* 0.22 −0.18 0.06 −0.06 −0.02 −0.08 0.38 −0.15 0.24 0.43* −0.44* 0.17 N/A
*

Note. = significant at the p<0.05 level;

**

= significant at the p<0.01 level;

***

= significant at the p<0.001 level. Entries marked “N/A” cannot be compared because no patients answered both survey items.

Table 6.

Annual ED Population Statistics

Category Characteristic N (% of visits) URI Visits (%)
Volume Visits 61,840 7,638 (12%)
Patients 53,557 6,347 (12%)

Gender Female 32,038 (52%) 4,383 (57%)

Ethnicity African-American 43,886 (71%) 6,041 (79%)
White 14,385 (23%) 1,296 (17%)
Hispanic 433 (1%) 32 (0%)
Other 3,136 (5%) 269 (4%)

Age 18-40 26,607 (43%) 3,475 (45%)
40-65 28,207 (46%) 3,295 (43%)
>65 7,026 (11%) 868 (11%)

Insurance Status Uninsured 10,636 (17%) 1,638 (21%)
Medicaid 25,045 (40%) 2,987 (39%)
Medicare 11,379 (18%) 1,469 (19%)
Commercial 12,430 (20%) 1,199 (16%)
Other 2,350 (4%) 345 (5%)

Note. URI = Upper Respiratory-tract Infection

Table 7.

Correlations of Item Agreement with Age and Education

Item Correlation
with
Education
Correlation
with Age
Correct Knowledge
 Yes against bacteria 0.28* 0.08
 No against bacteria −0.22 0.29
Germs are Germs
 Yes against viruses −0.39** 0.06
 No against viruses 0.43*** 0.18
 Yes against germs −0.26 −0.07
 No against germs 0.00 0.12
Why Not Take a Risk?
 Better safe than sorry −0.18 −0.23
 Better not to take ABX 0.20 0.13
 Take ABX just in case −0.21 0.07
 Don’t take ABX if they don’t make me better 0.18 0.16
 It can’t hurt −0.37** −0.04
 It might hurt −0.08 0.24
Antibiotics Might Have Side Effects
 ABX might have side effects 0.08 0.03
 ABX don’t have side effects −0.35* 0.04
I Need Antibiotics to Get Better
 My symptoms need ABX −0.15 0.01
 My symptoms don’t need ABX 0.14 0.04
 Will get better without ABX −0.08 −0.02
 Won’t get better without ABX −0.36** 0.18
Antibiotics Will Make Me Better
 ABX will make me better −0.35** 0.01
 ABX will keep me sick −0.12 −0.12
 ABX always cure 0.07 −0.05
 ABX don’t always cure 0.33** 0.14
Doctors Are Supposed to Give Antibiotics
 Dr. takes me seriously so gives ABX −0.28* −0.05
 Dr. takes me seriously regardless of ABX −0.38** −0.10
 Dr. may not give ABX even if s/he believes me 0.31* 0.05
 Dr. doesn’t believe me −0.33** −0.19
 Dr. knows best 0.25 −0.31*
 Dr. doesn’t know best −0.04 −0.03
 I trust Dr. to give ABX when I’m sick −0.13 −0.12
 I trust Dr. to give ABX only when needed −0.09 −0.13
I Visit the Doctor for an Antibiotic
 ABX are worth seeing Dr. −0.32* 0.00
 Seeing Dr. worth it without ABX −0.20 0.26
 Dr. gives ABX if I feel bad −0.50*** 0.16
 Feeling bad doesn’t mean Dr. gives ABX 0.24 −0.30*

Note. Age options were: 1) <24; 2) 25-29; 3) 30-39; 4) 40-49; 5) 50-64; 6) 65+. Education options were: 1) Did not complete high school; 2) High school (or equivalent); 3) Some college (1-4 years, no degree); 4) Associate’s degree (including occupational or academic degrees); 5) Bachelor’s degree (BA, BS AB, etc.); 6) Master’s degree (MA, MS, MENG, MSW, etc.); 7) Professional school degree (MD, DDC, JD, etc.); 8) Doctorate degree (PhD, EdD, etc.).

*

significant at the p<0.05 level;

**

significant at the p<0.01 level;

***

significant at the p<0.001 level. There was no significant overall correlation between age and level of education

References

  • 1.Shapiro E. Injudicious antibiotic use: An unforeseen consequence of the emphasis on patient satisfaction? Clinical Therapeutics. 2002;24(1):197–204. doi: 10.1016/s0149-2918(02)85015-9. [DOI] [PubMed] [Google Scholar]
  • 2.Ong S, Nakase J, Moran GJ, Karras DJ, Kuehnert MJ, Talan DA. Antibiotic use for emergency department patients with upper respiratory infections: prescribing practices, patient expectations, and patient satisfaction. Annals of Emergency Medicine. 2007;50(3):213–20. doi: 10.1016/j.annemergmed.2007.03.026. [DOI] [PubMed] [Google Scholar]
  • 3.Butler CC, Rollnick S, Pill R, Maggs-Rapport F, Stott N. Understanding the culture of prescribing: qualitative study of general practitioners’ and patients’ perceptions of antibiotics for sore throats. BMJ. 1998;317(7159):637–42. doi: 10.1136/bmj.317.7159.637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Reyna VF. A theory of medical decision making and health: Fuzzy-trace theory. Medical Decision Making. 2008;28(6):850–65. doi: 10.1177/0272989X08327066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Stearns CR, Gonzales R, Camargo CA, Maselli J, Metlay JP. Antibiotic prescriptions are associated with increased patient satisfaction with emergency department visits for acute respiratory tract infections. Academic Emergency Medicine. 2009;16(10):934–41. doi: 10.1111/j.1553-2712.2009.00522.x. [DOI] [PubMed] [Google Scholar]
  • 6.Reyna VF, Adam MB. Fuzzy-trace theory, risk communication, and product labeling in sexually transmitted diseases. Risk Analysis. 2003;23(2):325–42. doi: 10.1111/1539-6924.00332. [DOI] [PubMed] [Google Scholar]
  • 7.Adam MB, Reyna VF. Coherence and correspondence criteria for rationality: Experts’ estimation of risks of sexually transmitted infections. Journal of Behavioral Decision Making. 2005;18(3):169–86. [Google Scholar]
  • 8.Reyna VF, Nelson WL, Han PK, Dieckmann NF. How numeracy influences risk comprehension and medical decision making. Psychological Bulletin. 2009;135(6):943. doi: 10.1037/a0017327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Reyna VF. Risk perception and communication in vaccination decisions: A fuzzy-trace theory approach. Vaccine. 2012;30(25):3790–7. doi: 10.1016/j.vaccine.2011.11.070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Reyna VF, Brainerd CJ. Numeracy, ratio bias, and denominator neglect in judgments of risk and probability. Learning and Individual Differences. 2008;18(1):89–107. [Google Scholar]
  • 11.CDC - Get Smart: Antibiotic Resistance Questions and Answers [Internet] [downloaded 2013 Jul 10]. Available from: http://www.cdc.gov/getsmart/antibiotic-use/antibiotic-resistance-faqs.html#bacteria-viruses.
  • 12.Mills B, Reyna VF, Estrada S. Explaining Contradictory Relations Between Risk Perception and Risk Taking. Psychological Science. 2008 May 1;19(5):429–33. doi: 10.1111/j.1467-9280.2008.02104.x. [DOI] [PubMed] [Google Scholar]
  • 13.Reyna VF, Estrada SM, DeMarinis JA, Myers RM, Stanisz JM, Mills BA. Neurobiological and memory models of risky decision making in adolescents versus young adults. Journal of Experimental Psychology: Learning, Memory, and Cognition. 2011;37(5):1125–42. doi: 10.1037/a0023943. [DOI] [PubMed] [Google Scholar]
  • 14.Reyna VF, Mills BA. Theoretically Motivated Interventions for Reducing Sexual Risk Taking in Adolescence: A Randomized Controlled Experiment Applying Fuzzy-trace Theory. Journal of Experimental Psychology: General. doi: 10.1037/a0036717. In press. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Fabrigar LR, Wegener DT, MacCallum RC, Strahan EJ. Evaluating the use of exploratory factor analysis in psychological research. Psychological methods. 1999;4(3):272–99. [Google Scholar]
  • 16.Reyna VF, Chick CF, Corbin JC, Hsia AN. Developmental Reversals in Risky Decision Making Intelligence Agents Show Larger Decision Biases Than College Students. Psychological science. 2014;25(1):76–84. doi: 10.1177/0956797613497022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL. National surveillance of emergency department visits for outpatient adverse drug events. JAMA: the journal of the American Medical Association. 2006;296(15):1858–66. doi: 10.1001/jama.296.15.1858. [DOI] [PubMed] [Google Scholar]
  • 18.Shehab N, Patel PR, Srinivasan A, Budnitz DS. Emergency department visits for antibiotic-associated adverse events. Clinical Infectious Diseases. 2008;47(6):735–43. doi: 10.1086/591126. [DOI] [PubMed] [Google Scholar]
  • 19.Etminan M, Forooghian F, Brophy JM, Bird ST, Maberley D. Oral fluoroquinolones and the risk of retinal detachment. JAMA: The Journal of the American Medical Association. 2012;307(13):1414–9. doi: 10.1001/jama.2012.383. [DOI] [PubMed] [Google Scholar]
  • 20.Lapi F, Wilchesky M, Kezouh A, Benisty JI, Ernst P, Suissa S. Fluoroquinolones and the risk of serious arrhythmia: a population-based study. Clinical Infectious Diseases. 2012;55(11):1457–65. doi: 10.1093/cid/cis664. [DOI] [PubMed] [Google Scholar]
  • 21.Mainous AG, III, Hueston WJ. The cost of antibiotics in treating upper respiratory tract infections in a Medicaid population. Archives of Family Medicine. 1998;7(1):45. doi: 10.1001/archfami.7.1.45. [DOI] [PubMed] [Google Scholar]
  • 22.Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proceedings of the National Academy of Sciences. 1999;96(3):1152–6. doi: 10.1073/pnas.96.3.1152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Sun L, Klein EY, Laxminarayan R. Seasonality and temporal correlation between community antibiotic use and resistance in the United States. Clinical Infectious Diseases. 2012;55(5):687–94. doi: 10.1093/cid/cis509. [DOI] [PubMed] [Google Scholar]
  • 24.Hay AD, Thomas M, Montgomery A, Wetherell M, Lovering A, McNulty C, et al. The relationship between primary care antibiotic prescribing and bacterial resistance in adults in the community: a controlled observational study using individual patient data. Journal of Antimicrobial Chemotherapy. 2005;56(1):146–53. doi: 10.1093/jac/dki181. [DOI] [PubMed] [Google Scholar]
  • 25.Reyna VF. A new intuitionism: Meaning, memory, and development in fuzzy-trace theory. Judgment and Decision Making. 2012;7(3):332–59. [PMC free article] [PubMed] [Google Scholar]
  • 26.Wolfe CR, Reyna VF, Widmer CL, Cedillos EM, Fisher CR, Brust-Renck PG, et al. Efficacy of a web-based intelligent tutoring system for communicating genetic risk of breast cancer: A Fuzzy-trace theory approach. Medical Decision Making. 2014 doi: 10.1177/0272989X14535983. Advance online publication. doi: 10.1177/0272989X14535983. - [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Reyna VF, Mills BA. Theoretically motivated interventions for reducing sexual risk taking in adolescence: A randomized controlled experiment applying fuzzy-trace theory. Journal of Experimental Psychology: General. 2014 doi: 10.1037/a0036717. Advance online publication. doi: 10.1037/a0036717. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES